These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26846851)

  • 21. Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.
    Kim SH; Kim H; Ku HJ; Park JH; Cha H; Lee S; Lee JH; Park JW
    Redox Biol; 2016 Dec; 10():211-220. PubMed ID: 27810736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
    Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
    Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization.
    Tu L; Wang JH; Barathi VA; Prea SM; He Z; Lee JH; Bender J; King AE; Logan GJ; Alexander IE; Bee YS; Tai MH; Dusting GJ; Bui BV; Zhong J; Liu GS
    Angiogenesis; 2018 Feb; 21(1):95-109. PubMed ID: 29318471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development.
    Hanout M; Ferraz D; Ansari M; Maqsood N; Kherani S; Sepah YJ; Rajagopalan N; Ibrahim M; Do DV; Nguyen QD
    Biomed Res Int; 2013; 2013():830837. PubMed ID: 24319688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization.
    McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH
    PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.
    Wu J; Ke X; Fu W; Gao X; Zhang H; Wang W; Ma N; Zhao M; Hao X; Zhang Z
    Molecules; 2016 Dec; 21(12):. PubMed ID: 28009852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish.
    van Rooijen E; Voest EE; Logister I; Bussmann J; Korving J; van Eeden FJ; Giles RH; Schulte-Merker S
    Dis Model Mech; 2010; 3(5-6):343-53. PubMed ID: 20335444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization].
    Bonne C
    J Fr Ophtalmol; 2005 Mar; 28(3):326-30. PubMed ID: 15883500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and ex vivo retina angiogenesis assays.
    Rezzola S; Belleri M; Gariano G; Ribatti D; Costagliola C; Semeraro F; Presta M
    Angiogenesis; 2014 Jul; 17(3):429-42. PubMed ID: 24121991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
    Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
    Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable anti-angiogenic scaffolds for treatment of neovascular ocular pathologies.
    Sarkar B; Siddiqui Z; Kim KK; Nguyen PK; Reyes X; McGill TJ; Kumar VA
    Drug Deliv Transl Res; 2020 Oct; 10(5):1191-1202. PubMed ID: 32232681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
    Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
    Duan J; Du C; Shi Y; Liu D; Ma J
    Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic therapy for ischemic retinopathies.
    Al-Latayfeh M; Silva PS; Sun JK; Aiello LP
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a006411. PubMed ID: 22675660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.